Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder.
BACKGROUND
The Royal Australian and New Zealand College of Psychiatrists is co-ordinating the development of clinical practice guidelines (CPGs) in psychiatry, funded under the National Mental Health Strategy (Australia) and the New Zealand Health Funding Authority


METHODS
For these guidelines, the CPG team reviewed the treatment outcome literature (including meta-analyses) and consulted with practitioners and consumers.


CONCLUSIONS
This guideline provides evidence-based recommendations for the management of bipolar disorder by phase of illness, that is acute mania, mixed episodes and bipolar depression, and the prophylaxis of such episodes. It specifies the roles of various mood-stabilizing medications and of psychological treatments such as cognitive therapy and psycho-education.
D000927:Anticonvulsants / Q000097:blood / Q000145:classification / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000097:blood / Q000145:classification / Q000627:therapeutic use*; D001315:Australia; D001714:Bipolar Disorder / Q000188:drug therapy / Q000628:therapy*; D003131:Combined Modality Therapy; D016903:Drug Monitoring / Q000379:methods; D004565:Electroconvulsive Therapy / Q000379:methods*; D006801:Humans; D008605:Mental Health Services; D009520:New Zealand; D011575:Psychoanalytic Therapy / Q000379:methods; D016032:Randomized Controlled Trials as Topic
D000927:Anticonvulsants; D014150:Antipsychotic Agents